Entera Bio And 3 Other Stocks Under $1 Insiders Are Buying
Portfolio Pulse from Avi Kapoor
Insiders at four companies have recently made notable purchases of their own company's stock. Entera Bio Ltd. (ENTX) Director Haya Taitel bought shares at $0.77 each after the company received an extension from Nasdaq to regain compliance. OPKO Health, Inc. (OPK) 10% owner Frost Gamma Investments Trust purchased shares at $0.94 each following the pricing of a $200 million convertible notes offering. Fresh Tracks Therapeutics, Inc. (FRTX) 10% owner Exploration Capital LLC acquired shares at $0.98 each as the company plans a special meeting to seek approval of liquidation. Vista Gold Corp. (VGZ) Director Tracy Austin Stevenson bought shares at $0.37 each after the company announced a $20 million royalty agreement with Wheaton Precious Metals.
January 12, 2024 | 12:48 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Entera Bio Ltd. Director Haya Taitel purchased 7,615 shares at $0.77 each. The company received a Nasdaq compliance extension.
The insider purchase combined with the Nasdaq compliance extension could be seen as a positive sign by investors, potentially leading to a short-term increase in stock price.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
OPKO Health's 10% owner Frost Gamma Investments Trust acquired 511,531 shares at $0.94 each after a $200 million convertible notes offering.
The significant insider purchase following a convertible notes offering may indicate a bullish sentiment from the owner, potentially affecting the stock positively in the short term.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 80
POSITIVE IMPACT
Vista Gold Corp. Director Tracy Austin Stevenson acquired 20,000 shares at $0.37 each following a $20 million royalty agreement announcement.
The director's purchase, coupled with the recent positive news of a royalty agreement, could lead to a short-term uptick in the stock's price.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 75
NEUTRAL IMPACT
Fresh Tracks Therapeutics' 10% owner Exploration Capital LLC bought 51,502 shares at $0.98 each as the company prepares for a special meeting regarding liquidation.
The insider purchase occurs as the company is seeking stockholder approval for liquidation, which creates uncertainty and could neutralize the impact on the stock price.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 70